Skip to main content
. Author manuscript; available in PMC: 2017 Dec 19.
Published in final edited form as: Clin Transplant. 2016 Jun 22;30(7):845–851. doi: 10.1111/ctr.12758

TABLE 2.

Total, MCT cells, MCTC cells, and ratio of MCTC to MCT cells for all the groups*

Early normal group Late normal group ACR group CLAD group
Days since transplant 79.6±22.7 309.4±38.4 169.6±117 714.6±219
Total MC (per HPF) 11.4±6.7 21.5±3.9 17.5±7.2       27±10.8
MCT cells(per HPF) 9.8±6.4 19±6.1 14.8±7.3    18.9±10.5
MCTC cells (per HPF) 1.6±1.7 2.5±2.3   2.7±3.5     8.2±4.9
Ratio (%) 14.4±11.8 12.4±10.4 15.8±18     43.5±12.5

ACR, acute cellular rejection; CLAD, chronic lung allograft dysfunction.

*

Mean with standard deviation calculated using results of individual high-power field reads for each biopsy (n=10 per biopsy for 5 patients) resulting in total of 50 variables per group